Cola cure? Study sheds light on soda’s potential for common holiday medical emergency

Researchers performed a randomized controlled trial (RCT) to evaluate the safety and effectiveness of cola in relieving esophageal meal bolus impaction.

Historic approval of sickle cell gene therapies met with cautious optimism by experts at ASH

SAN DIEGO — News of the Food and Drug Administration’s historic approval of the first gene therapies for sickle cell disease sparked discussion, debate, and,

December 9, 2023

SEC fines former Merck exec over insider trading allegations

The Securities and Exchange Commission said a former Merck executive agreed to pay $82,000 after alleging he purchased shares of a company right before it was acquired by the drugmaker. Nirdosh

July 20, 2023

One Way to Spot Early Cognitive Decline? Medicare Wellness Visits

Medicare annual wellness visits were associated with a 21% increase in mild cognitive impairment diagnoses. Those with a wellness evaluation received a diagnosis 76 days

October 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.